Biogen, Amgen, Pfizer, Genentech and Sanofi have teamed with an MIT-led group aiming to develop new biomanufacturing cell lines and methods. The collaboration – known as the AltHost Consortium – will share research to explore innovative ways to produce biologics and vaccines for clinical usage in diseases from diabetes to cancer. Lead researcher Christopher Love from MIT likened the collaboration to the early days of the biopharmaceutical industry. “When biomanufacturing first emerged as a field, shared knowledge across laboratories was…